Brian A. Deck
Brian A. Deck's purchase track record
Brian A. Deck has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/28/2022 | JBTM | $136K | +18.3% | +17.7% | +6.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
JBTM mentioned in stock watchlists amid soft price action. Recent articles from Yahoo Finance have included JBT Marel in lists of stocks to monitor, often alongside other industrial names. These mentions highlight the company's presence in current market discussions despite recent price weakness. The stock is currently trading near its 52-week low, which provides context for why analysts are keeping a close eye on its performance.
Transaction History
| SPXC | ▲ Buy | Grant | 542 | — | 7/27/2026 | View on chart |
| JBTM | ▼ Sell | Open Market | 8,634 | $1.3M | 3/3/2026 | View on chart |
| JBTM | ▼ Sell | Open Market | 10,000 | $1.5M | 3/2/2026 | View on chart |
| JBTM | ▼ Sell | Tax Withholding | 2,508 | $386K | 2/27/2026 | View on chart |
| JBTM | ▼ Sell | Tax Withholding | 2,425 | $382K | 2/26/2026 | View on chart |
| JBTM | ▲ Buy | Grant | 30,495 | $0 | 2/25/2026 | View on chart |
| JBTM | ▼ Sell | Tax Withholding | 14,425 | $2.4M | 2/25/2026 | View on chart |
| JBTM | ▲ Buy | Grant | 16,072 | $0 | 2/25/2026 | View on chart |
| JBTM | ▼ Sell | Tax Withholding | 2,069 | $338K | 2/23/2026 | View on chart |
| JBTM | ▼ Sell | Tax Withholding | 2,349 | $309K | 2/27/2025 | View on chart |
| JBTM | ▲ Buy | Grant | 25,159 | $0 | 2/26/2025 | View on chart |
| JBTM | ▼ Sell | Tax Withholding | 11,146 | $1.3M | 2/26/2025 | View on chart |
| JBTM | ▲ Buy | Grant | 15,379 | $0 | 2/26/2025 | View on chart |
| JBTM | ▼ Sell | Tax Withholding | 5,426 | $636K | 2/24/2025 | View on chart |
| JBTM | ▼ Sell | Tax Withholding | 1,937 | $227K | 2/24/2025 | View on chart |
| JBTM | ▼ Sell | Tax Withholding | 3,143 | $327K | 3/8/2024 | View on chart |
| JBTM | ▼ Sell | Tax Withholding | 3,394 | $353K | 3/8/2024 | View on chart |
| JBTM | ▲ Buy | Grant | 15,907 | $0 | 2/27/2024 | View on chart |
| JBTM | ▲ Buy | Grant | 7,661 | $0 | 2/27/2024 | View on chart |
| JBTM | ▼ Sell | Tax Withholding | 1,937 | $193K | 2/22/2024 | View on chart |
| JBTM | ▼ Sell | Tax Withholding | 985 | $103K | 5/15/2023 | View on chart |
| JBTM | ▼ Sell | Tax Withholding | 385 | $40K | 3/10/2023 | View on chart |
| JBTM | ▼ Sell | Tax Withholding | 1,603 | $168K | 3/10/2023 | View on chart |
| JBTM | ▲ Buy | Grant | 2,222 | $244K | 2/22/2023 | View on chart |
| JBTM | ▲ Buy | Grant | 868 | $95K | 2/22/2023 | View on chart |
| JBTM | ▲ Buy | Grant | 13,116 | $0 | 2/22/2023 | View on chart |
| JBTM | ▲ Buy | Open Market | 1,500 | $136K | 10/28/2022 | View on chart |
| JBTM | ▼ Sell | Tax Withholding | 1,584 | $192K | 4/1/2022 | View on chart |
| JBTM | ▼ Sell | Tax Withholding | 238 | $29K | 4/1/2022 | View on chart |
| JBTM | ▲ Buy | Grant | 536 | $0 | 2/24/2022 | View on chart |
| JBTM | ▲ Buy | Grant | 12,243 | $0 | 2/24/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
SPXC receives analyst coverage and growth focus
Recent analyst notes emphasize SPX Technologies' growth profile, citing its market position and revenue trends. Oppenheimer kept an Outperform rating but adjusted its price target to $270, reflecting a more modest outlook. A separate piece highlighted the compound return of a $100 investment over 15 years, underscoring the stock’s long‑term performance while it trades near the lower end of its 52‑week range.
SPXC receives analyst coverage and growth focus. Recent analyst notes emphasize SPX Technologies' growth profile, citing its market position and revenue trends. Oppenheimer kept an Outperform rating but adjusted its price target to $270, reflecting a more modest outlook. A separate piece highlighted the compound return of a $100 investment over 15 years, underscoring the stock’s long‑term performance while it trades near the lower end of its 52‑week range.